Improved Production Efficiency of Virus-Like Particles by the Baculovirus Expression Vector System.
Ontology highlight
ABSTRACT: Vaccines based on virus-like particles (VLPs) have proven effective in humans and animals. In this regard, the baculovirus expression vector system (BEVS) is one of the technologies of choice to generate such highly immunogenic vaccines. The extended use of these vaccines for human and animal populations is constrained because of high production costs, therefore a significant improvement in productivity is crucial to ensure their commercial viability. Here we describe the use of the previously described baculovirus expression cassette, called TB, to model the production of two VLP-forming vaccine antigens in insect cells. Capsid proteins from porcine circovirus type 2 (PCV2 Cap) and from the calicivirus that causes rabbit hemorrhagic disease (RHDV VP60) were expressed in insect cells using
SUBMITTER: Lopez-Vidal J
PROVIDER: S-EPMC4601761 | biostudies-literature | 2015
REPOSITORIES: biostudies-literature
ACCESS DATA